Regulation of inducible nitric oxide synthase gene expression in vascular smooth muscle cells

General Pharmacology

Volumn 32, Issue 1, 1999, Pages 9-16

  Hecker, Markus ^a   Cattaruzza, Marco ^a   Wagner, Andreas H ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Cytokines; Gene expression; Gene therapy; Inflammation; Molecular drugs; Nitric oxide synthase; Protein kinases; Shock; Transcription factors; Vascular smooth muscle cells

Indexed keywords

ANTIOXIDANT; CALCIUM ANTAGONIST; CALCIUM ION; COUMARIN; DIHYDROPYRIDINE DERIVATIVE; IBUPROFEN; NIFEDIPINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEIN KINASE; SUPEROXIDE; TRANSCRIPTION FACTOR; VASOCONSTRICTOR AGENT;

ANGIOPLASTY; ENZYME INDUCTION; FEEDBACK SYSTEM; GENE INDUCTION; GENE TRANSFER; HEMOSTASIS; INFLAMMATION; PRIORITY JOURNAL; RESTENOSIS; REVIEW; SEPTIC SHOCK; TRANSCRIPTION REGULATION; VASCULAR DISEASE; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

ANIMALS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEMOSTASIS; HUMANS; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PROTEIN KINASES; SUPEROXIDES; TRANSCRIPTION, GENETIC;

EID: 0032890147     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(98)00082-2     Document Type: Review

References (86)

1. Akira S., Kishimoto T. NF-IL6 and NF-κB in cytokine gene regulation. Adv. Immunol. 65:1997;1-46.
2. Arthur J.F., Yin Z.L., Young H.M., Dusting G.J. Induction of nitric oxide synthase in the neointima induced by a periarterial collar in rabbits. Arterioscler. Thromb. Vasc. Biol. 17:1997;737-740.
3. Auerbach G., Nar H. The pathway from GTP to tetrahydrobiopterin. three-dimensional structures of GTP cyclohydrolase I, a 6-pyruvoyl tetrahydropterin synthase Biol. Chem. 378:1997;185-192.
4. Boese M., Busse R., Mülsch A., Schini-Kerth V. Effect of cyclic GMP-dependent vasodilators on the expression of inducible nitric oxide synthase in vascular smooth muscle cells. role of cyclic AMP Br. J. Pharmacol. 119:1996;707-715.
5. Boota A., Zar H., Kim Y.M., Johnson B., Pitt B., Davies P. IL-1β stimulates superoxide and delayed peroxynitrite production by pulmonary vascular smooth muscle cells. Am. J. Physiol. 271:1996;L932-L938.
6. Brady T.C., Chang L.Y., Day B.J., Crapo J.D. Extracellular superoxide dismutase is upregulated with inducible nitric oxide synthase after NF-κB activation. Am. J. Physiol. 273:1997;L1002-L1006.
7. Chartrain N.A., Geller D.A., Koty P.P., Saitrin N.F., Nüssler A.K., Hoffmann E.P., Billiar T.R., Hutchinson N.I., Mudgett J.S. Molecular cloning, structure, and chromosomal localization of the human inducible nitric oxide synthase gene. J. Biol. Chem. 269:1994;6765-6772.
8. Chinery R., Brockmann J.A., Dransfield D.T., Coffey R.J. Antioxidant-induced nuclear translocation of CCAAT/enhancer-binding protein β. A critical role for protein kinase A-mediated phosphorylation of Ser299. J. Biol. Chem. 272:1997;30356-30361.
9. Diaz-Guerra M.J., Bodelon O.G., Velasco M., Whelan R., Parker P.J., Bosca L. Up-regulation of protein kinase C-ε promotes the expression of cytokine-inducible nitric oxide synthase in RAW 264.7 cells. J. Biol. Chem. 271:1996;32028-32033.
10. Durante W., Cheng K., Schafer A.I. Cyclic nucleotide regulation of interleukin-1β induced nitric oxide synthase expression in vascular smooth muscle cells. Thromb. Res. 75:1994;63-71.
11. Durante W., Kroll M.H., Orloff G.J., Cunningham J.M., Scott-Burden T., Vanhoutte P.M., Schafer A.I. Regulation of interleukin-1β-stimulated inducible nitric oxide synthase expression in cultured vascular smooth muscle cells by hemostatic proteins. Biochem. Pharmacol. 51:1996;847-853.
12. Eberhardt W., Kunz D., Pfeilschifter J. Pyrrolidine dithiocarbamate differently affects interleukin-1β and cAMP-induced nitric oxide synthase expression in rat renal mesangial cells. Biochem. Biophys. Res. Commun. 200:1994;163-170.
13. Eberhardt W., Kunz D., Hummel R., Pfeilschifter J. Molecular cloning of the rat inducible nitric oxide synthase gene promotor. Biochem. Biophys. Res. Commun. 223:1996;752-756.
14. Feldmann I.J., Tahlil O., Steg G. Perspectives of arterial gene therapy for the prevention of restenosis. Cardiovasc. Res. 32:1996;194-207.
15. Finder J., Stark W.W. Jr., Nakayama D.K., Geller D., Wasserloos K., Pitt B.R., Davies P. TGF-β regulates production of NO in pulmonary artery smooth muscle cells by inhibiting expression of NOS. Am. J. Physiol. 268:1995;L862-L867.
16. 2+ selectively suppresses IL-1-induced NO production by reducing iNOS mRNA stability. J. Cell Biol. 129:1995;1651-1657.
17. Geng Y.J., Wu Q., Hansson G.K. Protein kinase C activation inhibits cytokine-induced nitric oxide synthesis in vascular smooth muscle cells. Biochem. Biophys. Acta. 1223:1994;125-132.
18. Greenberg S.S., Zhao X., Wang J.F., Hua L., Ouyang J. cAMP and purinergic P2y receptors upregulate and enhance inducible NO synthase mRNA and protein in vivo. Am. J. Physiol. 273:1997;L967-L979.
19. Hattori Y., Gross S.S. Cycloheximide induces nitric oxide synthase mRNA in vascular smooth muscle cells by prolonging mRNA lifetime. Biochem. Mol. Biol. Int. 37:1995;439-445.
20. Hattori Y., Kasai K., So S., Hattori S., Banba N., Shimoda S. Effects of calcium channel antagonists on the induction of nitric oxide synthase in cultured cells by immunostimulants. Life Sci. 57:1995;1833-1840.
21. Hecker M., Sessa W.C., Harris H.J., Anggard E.E., Vane J.R. The metabolism of L-arginine and its significance for the biosynthesis of endothelium-derived relaxing factor. cultured endothelial cells recycle L-citrulline to L-arginine Proc. Natl. Acad. Sci. 87:1990;8612-8616.
22. Hecker M., Preiss C., Schini-Kerth V.B., Busse R. Antioxidants differentially affect nuclear factor κB-mediated nitric oxide synthase expression in vascular smooth muscle cells. FEBS Lett. 380:1996;224-228. a.
23. Hecker M., Preiss C., Klemm P., Busse R. Inhibition by antioxidants of nitric oxide synthase expression in murine macrophages. role of nuclear factor κB and interferon regulatory factor 1 Br. J. Pharmacol. 118:1996;2178-2184. b.
24. Hecker M., Preiss C., Schini-Kerth V.B. Induction by staurosporine of nitric oxide synthase expression in vascular smooth muscle cells. role of NF-κB, CREB and C/EBPβ Br. J. Pharmacol. 120:1997;1067-1074.
25. Hirokawa K., O'Shaughnessy K., Moore K., Ramrakha P., Wilkins M.R. Induction of nitric oxide synthase in cultured vascular smooth muscle cells. the role of cyclic AMP Br. J. Pharmacol. 112:1994;396-402.
26. Ikeda U., Yamamoto K., Maeda Y., Kanbe T., Shimada K. Endothelin-1 inhibits nitric oxide synthesis in vascular smooth muscle cells. Hypertension. 29:1997;65-69.
27. Imai T., Hirata Y., Kanno K., Marumo F. Induction of nitric oxide synthase by cyclic AMP in rat vascular smooth muscle cells. J. Clin. Invest. 93:1994;543-549.
28. Joly G.A., Ayres M., Kilbourn R.G. Potent inhibition of inducible nitric oxide synthase by geldanamycin, a tyrosine kinase inhibitor, in endothelial, smooth muscle cells, and in rat aorta. FEBS Lett. 403:1997;40-44.
29. Jordan M.L., Rominski B., Jaquins-Gerstl A., Geller D., Hoffman R.A. Regulation of inducible nitric oxide production by intracellular calcium. Surgery. 118:1995;138-145.
30. Kanno K., Hirata Y., Imai T., Marumo F. Induction of nitric oxide synthase gene by interleukin in vascular smooth muscle cells. Hypertension. 22:1993;34-39.
31. Kinugawa K., Shimizu T., Yao A., Kohmoto O., Serizawa T., Takahashi T. Transcriptional regulation of inducible nitric oxide synthase in cultured neonatal rat cardiac myocytes. Circ. Res. 81:1997;911-921.
32. Kolyada A.Y., Savikovsky N., Madias N.E. Transcriptional regulation of the human iNOS gene in vascular-smooth-muscle cells and macrophages. evidence for tissue specificity Biochem. Biophys. Res. Commun. 220:1996;600-605.
33. Kunz D., Walker G., Eberhardt W., Messmer U.K., Huwiler A., Pfeilschifter J. Platelet-derived growth factor and fibroblast growth factor differentially regulate interleukin 1β- and cAMP-induced nitric oxide synthase expression in rat renal mesangial cells. J. Clin. Invest. 100:1997;2800-2809.
34. Kwon G., Corbett J.A., Rodi C.P., Sullivan P., McDaniel M.L. Interleukin-1β-induced nitric oxide synthase expression by rat pancreatic β-cells. evidence for the involvement of nuclear factor κB in the signaling mechanism Endocrinology. 136:1995;4790-4795.
35. Lefkovits J., Topol E.J. Pharmacological approaches for the prevention of restenosis after percutaneous coronary intervention. Prog. Cardiovasc. Dis. 40:1997;141-158.
36. Lin A.W., Chang C.C., McCormick C.C. Molecular cloning and expression of an avian macrophage nitric-oxide synthase cDNA and the analysis of the genomic 5′-flanking region. J. Biol. Chem. 271:1996;11911-11919.
37. Liu S.F., Barnes P.J., Evans T.W. Time course and cellular localization of lipopolysaccharide-induced inducible nitric oxide synthase messenger RNA expression in the rat in vivo. Crit. Care. Med. 25:1997;512-518. a.
38. Liu S.F., Ye X., Malik A.B. In vivo inhibition of nuclear factor-κB activation prevents inducible nitric oxide synthase expression and systemic hypotension in a rat model of septic shock. J. Immunol. 159:1997;3976-3983. b.
39. Lowenstein C.J., Alley E.W., Raval P., Snowman A.M., Snyder S.H., Russel S.W., Murphy W.J. Macrophage nitric oxide synthase gene. two upstream regions mediate induction by interferon γ and lipopolysaccaride Proc. Natl. Acad. Sci. 90:1993;9730-9734.
40. Marczin N., Papapetropoulos A., Catravas J.D. Tyrosine kinase inhibitors suppress endotoxin- and IL-1β-induced NO synthesis in aortic smooth muscle cells. Am. J. Physiol. 265:1993;H1014-H1018.
41. Marczin N., Jilling T., Papapetropoulos A., Go C., Catravas J.D. Cytoskeleton-dependent activation of the inducible nitric oxide synthase in cultured aortic smooth muscle cells. Br. J. Pharmacol. 118:1996;1085-1094.
42. Martin E., Nathan C., Xie Q.-w. Role of interferon regulatory factor 1 in induction of nitric oxide synthase. J. Exp. Med. 180:1994;977-984.
43. Marumo T., Nakaki T., Hishikawa K., Hirahashi J., Suzuki H., Kato R., Saruta T. Natriuretic peptide-augmented induction of nitric oxide synthase through cyclic guanosine 3′,5′-monophosphate elevation in vascular smooth muscle cells. Endocrinology. 136:1995;2135-2142.
44. Mercurio F., Zhu H., Murray B.W., Shevchenko A., Bennett B.L., Li J., Young D.B., Barbosa M., Mann M., Manning A., Rao A. IKK-1 and IKK-2. cytokine-activated IκB kinases essential for NF-κB activation Science. 278:1997;860-866.
45. Miller B.W., Baier L.D., Morrison A.R. Overexpression of protein kinase C-ζ isoform increases cyclooxygenase-2 and inducible nitric oxide synthase. Am. J. Physiol. 273:1997;C130-C136.
46. Miyasaka N., Hirata Y. Nitric oxide and inflammatory arthritides. Life. Sci. 61:1997;2073-2081.
47. Moritoki H., Hisayama T., Takeguchi S., Kondoh W., Takej Y. Possible involvement of tyrosine kinase in the LPS-promoted initiation of the L-arginine-induced relaxation of rat aorta mediated by induction of NO synthase. Life Sci. 57:1995;125-130.
48. Morris S.M., Billiar T.R. New insights into the regulation of inducible nitric oxide synthesis. Am. J. Physiol. 266:1994;E829-E839.
49. Mühl H., Pfeilschifter J. Possible role of protein kinase C-ε isoenzyme in inhibition of interleukin 1β induction of nitric oxide synthase in rat renal mesangial cells. Biochem. J. 303:1994;607-612.
50. Mühl H., Pfeilschifter J. Amplification of nitric oxide synthase expression by nitric oxide in interleukin 1 beta-stimulated rat mesangial cells. J. Clin. Invest. 95:1995;1941-1946.
51. Nakayama I., Kawahara Y., Tsuda T., Okuda M., Yokoyama M. Angiotensin II inhibits cytokine-stimulated inducible nitric oxide synthase expression in vascular smooth muscle cells. J. Biol. Chem. 269:1994;11628-11633.
52. Nathan C., Xie Q.-w. Nitric oxide synthases. role, tolls, and controls Cell. 78:1994;915-918.
53. Oddis C.V., Simmons R.L., Hattler B.G., Finkel M.S. Extracellular superoxide dismutase is upregulated with inducible nitric oxide synthase after NF-κB activation. Am. J. Physiol. 269:1995;H2044-H2050.
54. Paul A., Doherty K., Plevin R. Differential regulation by protein kinase C isoforms of nitric oxide synthase induction in RAW 264.7 macrophages and rat aortic smooth muscle cells. Br. J. Pharmacol. 120:1997;940-946.
55. Perrella M.A., Yoshizumi M., Fen Z., Tsai J.C., Hsieh C.M., Kourembanas S., Lee M.E. Transforming growth factor-β 1, but not dexamethasone, down-regulates nitric-oxide synthase mRNA after its induction by interleukin-1β in rat smooth muscle cells. J. Biol. Chem. 269:1994;14595-14600.
56. Presta A., Siddhanta U., Wu C., Sennequier N., Huang L., Abu-Soud H.M., Erzurum S., Stuehr D.J. Comparative functioning of dihydro- and tetrahydropterins in supporting electron transfer, catalysis, and subunit dimerization in inducible nitric oxide synthase. Biochemistry. 37:1998;298-310.
57. Regnier C.H., Song H.Y., Gao X., Goeddel D.V., Cao Z., Rothe M. Identification and characterization of an IκB kinase. Cell. 90:1997;373-383.
58. Salzmann A.L. Nitric oxide in the gut. New. Horiz. 3:1995;352-364.
59. Schini-Kerth V.B., Fisslthaler B., Andersen Th.T., Fenton J.W., Vanhoutte P.M., Busse R. Thrombin prevents the expression of inducible nitric oxide synthase in vascular smooth muscle cells by a proteolytically-activated thrombin receptor. Thromb. Haemostasis. 74:1995;980-986.
60. Schini-Kerth V.B., Boese M., Busse R., Fisslthaler B., Mülsch A. N-alpha-tosyl-L-lysine chloromethylketone prevents expression of iNOS in vascular smooth muscle by blocking activation of NF-κB. Arterioscler. Thromb. Vasc. Biol. 17:1997;672-679.
61. Scott-Burden T., Elizondo E., Ge T., Boulanger C.M., Vanhoutte P.M. Simultaneous activation of adenylyl cyclase and protein kinase C induces production of nitric oxide by vascular smooth muscle cells. Mol. Pharmacol. 46:1994;274-282.
62. Scott-Burden T., Schini V.B., Elizondo E., Junquero D.C., Vanhoutte P.M. Platelet-derived growth factor suppresses and fibroblast growth factor enhances cytokine-induced production of nitric oxide by cultured smooth muscle cells. Effects on cell proliferation. Circ. Res. 71:1992;1088-1100.
63. Shears L.L., Kawaharada N., Tzeng E., Billiar T.R., Watkins S.C., Kovesdi I., Lizonova A., Pham S.M. Inducible nitric oxide synthase suppresses the development of allograft arteriosclerosis. J. Clin. Invest. 100:1997;2035-2042.
64. Sirsjo A., Soderkvist P., Sundqvist T., Carlsson M., Ost M., Gidlof A. Different induction mechanisms of mRNA for inducible nitric oxide synthase in rat smooth muscle cells in culture and in aortic strips. FEBS Lett. 338:1994;191-196.
65. Southan G.J., Szabo C. Selective pharmacological inhibition of distinct nitric oxide synthase isoforms. Biochem. Pharmacol. 51:1996;383-394.
66. Sowa G., Przewlocki R. Enhancing effect of staurosporine on NO production in rat peritoneal macrophages via a protein kinase C-independent mechanism. Br. J. Pharmacol. 116:1995;1711-1712.
67. Spiecker M., Peng H.B., Liao J.K. Inhibition of endothelial vascular cell adhesion molecule-1 expression by nitric oxide involves the induction and nuclear translocation of IκBα J. Biol. Chem. 272:1997;30969-30974.
68. Spink J., Evans T. Binding of the transcription factor interferon regulatory factor-1 to the inducible nitric-oxide synthase promoter. J. Biol. Chem. 272:1997;24417-24425.
69. Spink J., Cohen J., Evans T.J. The cytokine responsive vascular smooth muscle cell enhancer of inducible nitric oxide synthase. Activation by nuclear factor-κB. J. Biol. Chem. 270:1995;29541-29547.
70. Stein B., Baldwin A. Distinct mechanisms for regulation of the interleukin-8 gene involve synergism and co-operativity between C/EBP and NF-κB. Mol. Cell. Biol. 13:1993;7191-7198.
71. Szabo C., Mitchel J.A., Gross S.S., Thiemermann C., Vane J.R. Nifedipine inhibits the induction of nitric oxide synthase by bacterial lipopolysaccharide. J. Pharmacol. Exp. Ther. 265:1993;674-680.
72. Taylor B.S., Kim Y.M., Wang Q., Shapiro R.A., Billiar T.R., Geller D.A. Nitric oxide down-regulates hepatocyte-inducible nitric oxide synthase gene expression. Arch. Surg. 132:1997;1177-1183.
73. Tetsuka T., Srivastava S.K., Morrison A.R. Tyrosine kinase inhibitors, genistein and herbimycin A, do not block interleukin-1β-induced activation of NF-kB in rat mesangial cells. Biochem. Biophys. Res. Commun. 218:1996;808-812.
74. Thiemermann C. Nitric oxide and septic shock. Gen. Pharmacol. 29:1997;159-166.
75. Tzeng E., Yoneyama T., Hatakeyama K., Shears L.L., Billiar T.R. Vascular inducible nitric oxide synthase gene therapy. Surgery. 120:1996;315-321.
76. Ushio-Fukai M., Zafari A.M., Fukui T., Ishizaka N., Griendling K.K. p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J. Biol. Chem. 271:1996;23317-23321.
77. Walker G., Pfeilschifter J., Kunz D. Mechanisms of suppression of inducible nitric-oxide synthase (iNOS) expression in interferon (IFN)-γ-stimulated RAW 264.7 cells by dexamethasone. Evidence for glucocorticoid-induced degradation of iNOS protein by calpain as a key step in post-transcriptional regulation. J. Biol. Chem. 272:1997;16679-16687.
78. G-monomethyl-L-arginine. Biochem. J. 316:1996;209-215.
79. Xie L.J., Gross S.S. Argininosuccinate synthetase overexpression in vascular smooth muscle cells potentiates immunostimulant-induced NO production. J. Biol. Chem. 272:1997;16624-16630.
80. Xie Q.-w., Wishnan R., Nathan C. Promotor of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon-γ and bacterial lipopolysaccharide. J. Exp. Med. 177:1993;1779-1784.
81. Xie Q.-w., Kashiwabara Y., Nathan C. Role of transcription factor NF-κB/Rel in the induction of nitric oxide synthase. J. Biol. Chem. 269:1994;4705-4708.
82. Yamamoto K., Arakawa T., Ueda N., Yamamoto S. Transcriptional roles of nuclear factor κB and nuclear factor-interleukin-6 in the tumor necrosis factor alpha-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells. J. Biol. Chem. 270:1995;31315-31320.
83. Yamamoto K., Ikeda U., Okada K., Saito T., Shimada K. Arginine vasopressin inhibits nitric oxide synthesis in cytokine-stimulated vascular smooth muscle cells. Hypertens. Res. 20:1997;209-216.
84. Yan Z., Hansson G.K. Overexpression of inducible nitric oxide synthase by neointimal smooth muscle cells. Circ. Res. 82:1998;21-29.
85. Yan Z., Yokota T., Zhang W., Hansson G.K. Expression of inducible nitric oxide synthase inhibits platelet adhesion and restores blood flow in the injured artery. Circ. Res. 79:1996;38-44.
86. Zandi E., Rothwarf D.M., Delhase M., Hayakawa M., Karin M. The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phosphorylation and NF-κB activation. Cell. 91:1997;243-252.